Creative Planning Caladrius Biosciences, Inc. Transaction History

Creative Planning

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$1.4 - $1.9 $2,924 - $3,969	-2,089 Reduced 17.17%	10,075 $16,000
Q4 2020 Jan 29, 2021	BUY	$1.39 - $1.87 $2,903 - $3,906	2,089 Added 20.73%	12,164 $17,000
Q1 2020 May 05, 2020	SELL	$1.21 - $3.47 $22 - $65	-19 Reduced 0.19%	10,075 $18,000
Q3 2018 Oct 25, 2018	SELL	$4.85 - $6.5 $218 - $292	-45 Reduced 0.44%	10,094 $60,000
Q1 2018 Apr 18, 2018	BUY	$3.7 - $6.09 $166 - $274	45 Added 0.45%	10,139 $59,000
Q4 2017 Jan 17, 2018	BUY	$2.66 - $3.71 $26,850 - $37,448	10,094	10,094 $35,000

Ticker CLBS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,583,200
Market Cap $25.8M
Description
Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical li...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.